Jiangui He

898 total citations
60 papers, 623 citations indexed

About

Jiangui He is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jiangui He has authored 60 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jiangui He's work include Atrial Fibrillation Management and Outcomes (15 papers), Cardiac Arrhythmias and Treatments (15 papers) and Cardiovascular Function and Risk Factors (13 papers). Jiangui He is often cited by papers focused on Atrial Fibrillation Management and Outcomes (15 papers), Cardiac Arrhythmias and Treatments (15 papers) and Cardiovascular Function and Risk Factors (13 papers). Jiangui He collaborates with scholars based in China, Trinidad and Tobago and Belgium. Jiangui He's co-authors include Yili Chen, Yugang Dong, Xin He, Yue Zhou, Lingling Wu, Chen Liu, Shenglong Chen, Dexi Wu, Weihao Liang and Wengen Zhu and has published in prestigious journals such as Journal of Clinical Investigation, Journal of the American College of Cardiology and Stroke.

In The Last Decade

Jiangui He

55 papers receiving 615 citations

Peers

Jiangui He
Jiangui He
Citations per year, relative to Jiangui He Jiangui He (= 1×) peers Miodrag Janić

Countries citing papers authored by Jiangui He

Since Specialization
Citations

This map shows the geographic impact of Jiangui He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangui He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangui He more than expected).

Fields of papers citing papers by Jiangui He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangui He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangui He. The network helps show where Jiangui He may publish in the future.

Co-authorship network of co-authors of Jiangui He

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangui He. A scholar is included among the top collaborators of Jiangui He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangui He. Jiangui He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Min, Zexuan Wu, Chen Liu, et al.. (2025). Causal Associations Between Socioeconomic Status, Intelligence, Cognition and Atrial Fibrillation. JACC Asia. 5(8). 983–996.
2.
Chen, Chang, Xin He, Jingjing Zhao, et al.. (2025). Cerebral small vessel disease and cognitive dysfunction in relation to central systolic blood pressure. European Journal of Internal Medicine. 136. 101–106.
3.
Xu, Ting, Xiaodong Zhuang, Jialing Wu, et al.. (2024). Loss of NAT10 Reduces the Translation of Kmt5a mRNA Through ac4C Modification in Cardiomyocytes and Induces Heart Failure. Journal of the American Heart Association. 13(20). e035714–e035714. 6 indexed citations
4.
Wu, Yuzhong, Xin He, Jingjing Zhao, et al.. (2023). Prognostic Significance of Blood Pressure at Rest and After Performing the Six-Minute Walk Test in Patients With Acute Heart Failure. American Journal of Hypertension. 37(3). 199–206. 1 indexed citations
6.
He, Xin, Bin Dong, Weihao Liang, et al.. (2022). Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data. Atherosclerosis. 344. 1–6. 4 indexed citations
7.
Liang, Weihao, Jiangui He, Michael Fu, et al.. (2022). Phenotypes of Heart Failure with Preserved Ejection Fraction and Effect of Spironolactone Treatment. ESC Heart Failure. 9(4). 2567–2575. 19 indexed citations
8.
Liang, Weihao, Yuzhong Wu, Ruicong Xue, et al.. (2021). C2HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial. BMC Medicine. 19(1). 44–44. 12 indexed citations
9.
He, Xin, Bin Dong, Ruicong Xue, et al.. (2021). Effect of Aggressive Diuresis in Acute Heart Failure with Reduced and Preserved Ejection Fraction. ESC Heart Failure. 8(4). 3248–3256. 10 indexed citations
10.
Jiang, Ruhong, Minglong Chen, Jie Fan, et al.. (2020). Rationale and study design for ablation of paroxysmal atrial fibrillation guided by ablation index: a multi-center, prospective randomized trial (PAF-AI trial). Journal of Interventional Cardiac Electrophysiology. 60(3). 439–444. 2 indexed citations
11.
Wu, Yuzhong, Wengen Zhu, Xin He, et al.. (2020). Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial. British Journal of General Practice. 71(702). e62–e70. 17 indexed citations
12.
Yao, Yan, Feng Hu, Jiangui He, et al.. (2020). The value of extensive catheter linear ablation on persistent atrial fibrillation (the CLEAR-AF Study). International Journal of Cardiology. 316. 125–129. 14 indexed citations
13.
Chen, Yili, Cong Chen, Bin Dong, et al.. (2017). AMPK attenuates ventricular remodeling and dysfunction following aortic banding in mice via the Sirt3/Oxidative stress pathway. European Journal of Pharmacology. 814. 335–342. 19 indexed citations
14.
Wang, Lichun, Jingzhou Jiang, Chong Feng, et al.. (2016). The ventriculoatrial relationship after atrial overdrive pacing can help differentiate atrioventricular nodal reentrant tachycardia from junctional tachycardia. Journal of Interventional Cardiac Electrophysiology. 47(3). 293–298. 2 indexed citations
15.
Zhou, Yue, et al.. (2015). Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation. Biochemical and Biophysical Research Communications. 468(1-2). 394–399. 50 indexed citations
17.
He, Jiangui, et al.. (2009). B‐type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor‐β1/smad7 pathway in vivo and in vitro. Clinical and Experimental Pharmacology and Physiology. 37(3). 283–289. 18 indexed citations
18.
He, Jiangui, Yili Chen, Fengjuan Yao, et al.. (2008). Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats. European Journal of Pharmacology. 602(1). 132–137. 17 indexed citations
19.
Pei, Zhaohui, Hanfei Sang, Ruiman Li, et al.. (2007). Infrasound‐induced hemodynamics, ultrastructure, and molecular changes in the rat myocardium. Environmental Toxicology. 22(2). 169–175. 30 indexed citations
20.
Wang, Lichun, Hong Ma, Jiangui He, et al.. (2005). Effect of angiotensin converting enzyme inhibitor on the calcium transients and calcium handling proteins in ventricular myocytes from rats with heart failure.. PubMed. 118(9). 731–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026